<?xml version='1.0' encoding='utf-8'?>
<document id="29988367"><sentence text="Interactions Between Emodin and Efflux Transporters on Rat Enterocyte by a Validated Ussing Chamber Technique." /><sentence text="Emodin, a major active anthraquinone, frequently interacts with other drugs"><entity charOffset="0-6" id="DDI-PubMed.29988367.s2.e0" text="Emodin" /><entity charOffset="23-36" id="DDI-PubMed.29988367.s2.e1" text="anthraquinone" /><pair ddi="false" e1="DDI-PubMed.29988367.s2.e0" e2="DDI-PubMed.29988367.s2.e0" /><pair ddi="false" e1="DDI-PubMed.29988367.s2.e0" e2="DDI-PubMed.29988367.s2.e1" /></sentence><sentence text=" As changes of efflux transporters on intestine are one of the essential reasons why the drugs interact with each other, a validated Ussing chamber technique was established to detect the interactions between emodin and efflux transporters, including P-glycoprotein (P-gp), multidrug-resistant associated protein 2 (MRP2), and multidrug-resistant associated protein 3 (MRP3)" /><sentence text=" Digoxin, pravastatin, and teniposide were selected as the test substrates of P-gp, MRP2, and MRP3"><entity charOffset="1-8" id="DDI-PubMed.29988367.s4.e0" text="Digoxin" /><entity charOffset="10-21" id="DDI-PubMed.29988367.s4.e1" text="pravastatin" /><entity charOffset="27-37" id="DDI-PubMed.29988367.s4.e2" text="teniposide" /><pair ddi="false" e1="DDI-PubMed.29988367.s4.e0" e2="DDI-PubMed.29988367.s4.e0" /><pair ddi="false" e1="DDI-PubMed.29988367.s4.e0" e2="DDI-PubMed.29988367.s4.e1" /><pair ddi="false" e1="DDI-PubMed.29988367.s4.e0" e2="DDI-PubMed.29988367.s4.e2" /><pair ddi="false" e1="DDI-PubMed.29988367.s4.e1" e2="DDI-PubMed.29988367.s4.e1" /><pair ddi="false" e1="DDI-PubMed.29988367.s4.e1" e2="DDI-PubMed.29988367.s4.e2" /></sentence><sentence text=" Verapamil, MK571, and benzbromarone were their special inhibitors"><entity charOffset="23-36" id="DDI-PubMed.29988367.s5.e0" text="benzbromarone" /></sentence><sentence text=" The results showed that verapamil, MK571, and benzbromarone could increase digoxin, pravastatin, and teniposide absorption, and decrease their Er values, respectively"><entity charOffset="25-34" id="DDI-PubMed.29988367.s6.e0" text="verapamil" /><entity charOffset="36-41" id="DDI-PubMed.29988367.s6.e1" text="MK571" /><entity charOffset="47-60" id="DDI-PubMed.29988367.s6.e2" text="benzbromarone" /><entity charOffset="76-83" id="DDI-PubMed.29988367.s6.e3" text="digoxin" /><entity charOffset="85-96" id="DDI-PubMed.29988367.s6.e4" text="pravastatin" /><entity charOffset="102-112" id="DDI-PubMed.29988367.s6.e5" text="teniposide" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e0" e2="DDI-PubMed.29988367.s6.e0" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e0" e2="DDI-PubMed.29988367.s6.e1" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e0" e2="DDI-PubMed.29988367.s6.e2" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e0" e2="DDI-PubMed.29988367.s6.e3" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e0" e2="DDI-PubMed.29988367.s6.e4" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e0" e2="DDI-PubMed.29988367.s6.e5" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e1" e2="DDI-PubMed.29988367.s6.e1" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e1" e2="DDI-PubMed.29988367.s6.e2" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e1" e2="DDI-PubMed.29988367.s6.e3" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e1" e2="DDI-PubMed.29988367.s6.e4" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e1" e2="DDI-PubMed.29988367.s6.e5" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e2" e2="DDI-PubMed.29988367.s6.e2" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e2" e2="DDI-PubMed.29988367.s6.e3" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e2" e2="DDI-PubMed.29988367.s6.e4" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e2" e2="DDI-PubMed.29988367.s6.e5" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e3" e2="DDI-PubMed.29988367.s6.e3" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e3" e2="DDI-PubMed.29988367.s6.e4" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e3" e2="DDI-PubMed.29988367.s6.e5" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e4" e2="DDI-PubMed.29988367.s6.e4" /><pair ddi="false" e1="DDI-PubMed.29988367.s6.e4" e2="DDI-PubMed.29988367.s6.e5" /></sentence><sentence text=" Verapamil (220 μM) could significantly increase emodin absorption at 9"><entity charOffset="1-10" id="DDI-PubMed.29988367.s7.e0" text="Verapamil" /><entity charOffset="49-55" id="DDI-PubMed.29988367.s7.e1" text="emodin" /><pair ddi="false" e1="DDI-PubMed.29988367.s7.e0" e2="DDI-PubMed.29988367.s7.e0" /><pair ddi="false" e1="DDI-PubMed.29988367.s7.e0" e2="DDI-PubMed.29988367.s7.e1" /></sentence><sentence text="25 μM" /><sentence text=" In the presence of MK571 (186 μM), the Papp values of emodin from M-S were significantly increased and the efflux ratio decreased"><entity charOffset="55-61" id="DDI-PubMed.29988367.s9.e0" text="emodin" /><entity charOffset="20-25" id="DDI-PubMed.29988367.s9.e1" text="MK571" /><pair ddi="false" e1="DDI-PubMed.29988367.s9.e1" e2="DDI-PubMed.29988367.s9.e1" /><pair ddi="false" e1="DDI-PubMed.29988367.s9.e1" e2="DDI-PubMed.29988367.s9.e0" /></sentence><sentence text=" With the treatment of emodin (185, 370, and 740 μM), digoxin absorption was significantly decreased while teniposide increased"><entity charOffset="23-29" id="DDI-PubMed.29988367.s10.e0" text="emodin" /><entity charOffset="54-61" id="DDI-PubMed.29988367.s10.e1" text="digoxin" /><entity charOffset="107-117" id="DDI-PubMed.29988367.s10.e2" text="teniposide" /><pair ddi="false" e1="DDI-PubMed.29988367.s10.e0" e2="DDI-PubMed.29988367.s10.e0" /><pair ddi="false" e1="DDI-PubMed.29988367.s10.e0" e2="DDI-PubMed.29988367.s10.e1" /><pair ddi="false" e1="DDI-PubMed.29988367.s10.e0" e2="DDI-PubMed.29988367.s10.e2" /><pair ddi="false" e1="DDI-PubMed.29988367.s10.e1" e2="DDI-PubMed.29988367.s10.e1" /><pair ddi="false" e1="DDI-PubMed.29988367.s10.e1" e2="DDI-PubMed.29988367.s10.e2" /></sentence><sentence text=" These results indicated that emodin might be the substrate of P-gp and MRP2"><entity charOffset="30-36" id="DDI-PubMed.29988367.s11.e0" text="emodin" /></sentence><sentence text=" Besides, it might be a P-gp inducer and MRP3 inhibitor on enterocyte, which are reported for the first time" /><sentence text=" These results will be helpful to explain the drug-drug interaction mechanisms between emodin and other drugs and provide basic data for clinical combination therapy"><entity charOffset="87-93" id="DDI-PubMed.29988367.s13.e0" text="emodin" /></sentence><sentence text="" /></document>